Jiuding Specialization Investment Strategy's Impact On Liuzhou Pharmaceutical Company's Performance

Recent years,along with an active market,the rapid development of the domestic private equity,once presented the "National PE" phenomenon.With standardization and improvement of the market mechanism,the initial private equity explosive development come to an end,national PE gradually fading phenomenon,Chinese private equity industry has gradually bid farewell to era of huge profits,into the rational stage of development.However,after the last round of rapid development,high-quality projects in the market may invest became less and less,companies need no longer just a capital injection,which results in a large number of PE into an embarrassing situation.It is difficult for PE to find high-quality items or companies unwilling to accept only investment.Companies-to-PE proposed other requirements,including enterprise management optimization,higher value-added services.Faced with changes,some private equity had gradually changed the investment strategies,starting building professional industry investment fund,focusing on post-investment management,providing in addition to investments in more value-added services.This paper describes Jiuding Investment Management Ltd.invested Liuzhou Guangxi Pharmaceutical Company Limited.As a leading private equity,Jiuding Investment Management Ltd.was first established to determine the professional investment philosophy,with a wide range of value-added services to improve Liuzhou pharmaceutical company's solvency,enhance the profitability,enhance the performance of Liuzhou pharmaceutical.Finally,the added performance comparison of non-professional and professional investment strategy PE portfolio companies,as a complement to the case.